Kalmia Latifolia Pellet
Product Images NDC 15631-0255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Kalmia Latifolia (NDC 15631-0255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0255

Label Pellets Fda 15631 0255
This is a description of a homeopathic medicine called Kalmia Latifolia 3X. The text mentions the ingredients used in making the medicine, usage instruction for adults and children, safety precautions, and storage instructions. Not much context is given about the medicine's intended use or effectiveness, except for a claim of "temporary relief" from headaches.*
FDA Label Image

Mini Labels Pellets Fda15631 0255

Mini Labels Pellets Fda15631 0255
This text provides information on a medication that contains Kalmia Latifolia 3X used for temporary relief of headaches. The active ingredient is not mentioned clearly but it appears to be listed above. The medication comes in pellet form and should be taken as directed by a physician. It is suitable for adults and children over the age of 2 years. The medication is not approved by the FDA and is based on homeopathic practices. The packaging includes a mini label with a blister pack for selected pack sizes. The NDC number and other manufacturing details are available.*
FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack
This is a product description for a homeopathic medicine. The product is a single homeopathic remedy that is lactose-free and manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The product warns that it should only be used for certain conditions and should be discontinued if symptoms do not improve after four days or worsen. The product also advises pregnant or nursing individuals to seek advice from a healthcare professional. The product should be stored in a cool, dark place, and kept out of reach of children. It is distributed by Rehomeo Inc in Texas and manufactured in India by Rihomeo Private Limited. The label inside indicates that the product is lactose-free. The packaging comes in a variety of sizes and may include secondary packing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.